Contract analysis

I. EXECUTIVE SUMMARY Calderwood & Harkness LLP ("C&H") has been retained by Crestline Packaging Solutions LLC ("Crestline" or "CPS"), a Delaware limited liability company headquartered at 4100 Rockside Road, Suite 300, Independence, OH 44131, as buyer's counsel in connection with the proposed asset purchase of substantially all assets comprising the ProShield Industrial Coatings product line (the "ProShield Product L

1. Customer Contract Assignability / Change-of-Control Consent Requirements. Seven (7) of the twenty-three (23) active supply agreements included in the Transferred Assets contain anti-assignment or change-of-control consent provisions. Three (3) of these are among the top five (5) customer accounts by revenue, creating meaningful execution risk.

2. Customer Concentration Risk. The top five (5) customer accounts represent approximately 58% of ProShield Product Line revenue, concentrating Crestline's post-Closing revenue base and, critically, the earnout measurement in a limited number of commercial relationships.

3. Environmental Conditions at the Tonawanda Facility. While preliminary database searches have not identified the facility on any federal or state priority remediation lists, VCI's historical use of volatile organic compounds and solvents, together with the 2018 underground storage tank removal, warrant thorough environmental review. Final assessment is pending receipt of the Northbridge Phase I report.

4. IP Chain-of-Title Completeness. Approximately eight (8) of the forty-seven (47) proprietary formulations were developed by former employees who signed only general employment agreements lacking specific invention assignment or work-for-hire clauses. Additionally, approximately five (5) formulations were co-developed with a raw material supplier under a joint development agreement that includes notice/consent requi

5. Employee Transition Mechanics. As an asset purchase, there is no automatic transfer of employment. Crestline will need to extend offers to thirty-four (34) product line employees, address restrictive covenant assignment issues, and manage the transition of personnel from VCI's benefit plans to Crestline's plans, all while preserving continuity of manufacturing operations and customer relationships. Each of these i

II. CORPORATE ORGANIZATION AND AUTHORITY OF SELLER A. Entity Status and Good Standing Voss Chemical Industries, Inc. is a New York business corporation that was originally incorporated under the laws of the State of New York in 1987 by the Voss family. VCI has been continuously in existence since its date of incorporation and, based on our preliminary review, has maintained its corporate status in good standing throu

III. INTELLECTUAL PROPERTY The intellectual property assets of the ProShield Product Line represent a significant component of the Transaction's value proposition. Our review has focused on: (i) the ProShield trademark; (ii) the portfolio of forty-seven (47) proprietary coating formulations maintained as trade secrets; and (iii) the overall chain of title and freedom from encumbrances of the Transferred IP. The follo

IV. CUSTOMER CONTRACTS A. Overview of Assigned Contracts The Transferred Assets include twenty-three (23) active supply agreements (the "Assigned Contracts") between VCI and customers of the ProShield Product Line. These agreements govern the sale and supply of ProShield-branded industrial coatings to customers operating in the packaging, container, industrial manufacturing, and food-processing industries. We have ob

V. EMPLOYEES AND EMPLOYMENT MATTERS A. Transferred Employees Thirty-four (34) employees are currently associated with the ProShield Product Line and are expected to be included in the Transaction as part of the workforce transition (the "Transferred Employees"). The Transferred Employees are categorized as follows: Because the Transaction is structured as an asset purchase rather than a stock acquisition, there is no

VI. ENVIRONMENTAL MATTERS A. Tonawanda Facility The ProShield Product Line is manufactured at VCI's facility located at 790 Niagara Falls Boulevard, Tonawanda, NY 14150 (the "Facility" or the "Tonawanda Facility"). The Facility comprises approximately 42,000 square feet of manufacturing, laboratory, warehouse, and office space situated on a parcel of approximately 3.5 acres in an area zoned for industrial use. The Fa